Literature DB >> 25929961

Epidemiological Trends for HIV in Southern Africa: Implications for Reaching the Elimination Targets.

Brian G Williams1, Eleanor Gouws, Pierre Somse, Mpho Mmelesi, Chibwe Lwamba, Trouble Chikoko, Erika Fazito, Mohamed Turay, Eva Kiwango, Pepukai Chikukwa, Henry Damisoni, Michael Gboun.   

Abstract

Southern Africa is the region worst affected by HIV in the world and accounts for one third of the global burden of HIV. Achieving the UNAIDS 90-90-90 target by 2020 and ending the AIDS epidemic by 2030 depend on success in this region. We review epidemiological trends in each country in southern Africa with respect to the prevalence, incidence, mortality, coverage of anti-retroviral therapy (ART) and TB notification rates, to better understand progress in controlling HIV and TB and to determine what needs to be done to reach the UNAIDS targets. Significant progress has been made in controlling HIV. In all countries in the region, the prevalence of HIV in people not on ART, the incidence of HIV, AIDS-related mortality and, in most countries, TB notification rates, are falling. In some countries, the risk of infection began to fall before biomedical interventions such as ART became widely available as a result of effective prevention measures or people's awareness of, and response to, the epidemic but the reasons for these declines remain uncertain. Some countries have achieved better levels of ART coverage than others, but all are in a position to reach the 2020 and 2030 targets if they accelerate the roll-out of ART and of targeted prevention efforts. Achieving the HIV treatment targets will further reduce the incidence of HIV-related TB, but efforts to control TB in HIV-negative people must be improved and strengthened.

Entities:  

Mesh:

Year:  2015        PMID: 25929961     DOI: 10.1007/s11904-015-0264-x

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  22 in total

1.  Declining HIV prevalence and incidence in perinatal women in Harare, Zimbabwe.

Authors:  John W Hargrove; Jean H Humphrey; Agnes Mahomva; Brian G Williams; Henry Chidawanyika; Kuda Mutasa; Edmore Marinda; Michael T Mbizvo; Kusum J Nathoo; Peter J Iliff; Owen Mugurungi
Journal:  Epidemics       Date:  2011-03-02       Impact factor: 4.396

2.  HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations.

Authors:  Brian G Williams; Eline L Korenromp; Eleanor Gouws; George P Schmid; Bertran Auvert; Christopher Dye
Journal:  J Infect Dis       Date:  2006-10-03       Impact factor: 5.226

3.  The epidemiology of human immunodeficiency virus in South Africa.

Authors:  B G Williams; E Gouws
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-07-29       Impact factor: 6.237

4.  CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater.

Authors:  Luuk Gras; Anouk M Kesselring; James T Griffin; Ard I van Sighem; Christophe Fraser; Azra C Ghani; Frank Miedema; Peter Reiss; Joep M A Lange; Frank de Wolf
Journal:  J Acquir Immune Defic Syndr       Date:  2007-06-01       Impact factor: 3.731

Review 5.  A surprising prevention success: why did the HIV epidemic decline in Zimbabwe?

Authors:  Daniel T Halperin; Owen Mugurungi; Timothy B Hallett; Backson Muchini; Bruce Campbell; Tapuwa Magure; Clemens Benedikt; Simon Gregson
Journal:  PLoS Med       Date:  2011-02-08       Impact factor: 11.069

6.  Migration and Health in Southern Africa: 100 years and still circulating.

Authors:  Mark N Lurie; Brian G Williams
Journal:  Health Psychol Behav Med       Date:  2014-01-01

7.  Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.

Authors:  Reshma Kassanjee; Christopher D Pilcher; Sheila M Keating; Shelley N Facente; Elaine McKinney; Matthew A Price; Jeffrey N Martin; Susan Little; Frederick M Hecht; Esper G Kallas; Alex Welte; Michael P Busch; Gary Murphy
Journal:  AIDS       Date:  2014-10-23       Impact factor: 4.177

8.  HIV estimates at second subnational level from national population-based surveys.

Authors:  Joseph Larmarange; Victoria Bendaud
Journal:  AIDS       Date:  2014-11       Impact factor: 4.177

9.  Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa.

Authors:  Bertran Auvert; Elliot Marseille; Eline L Korenromp; James Lloyd-Smith; Remi Sitta; Dirk Taljaard; Carel Pretorius; Brian Williams; James G Kahn
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

10.  Outcomes of a community-based HIV-prevention pilot programme for township men who have sex with men in Cape Town, South Africa.

Authors:  Elizabeth Batist; Benjamin Brown; Andrew Scheibe; Stefan D Baral; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2013-12-02       Impact factor: 5.396

View more
  10 in total

Review 1.  Antiretroviral Therapy and Alcohol Interactions: X-raying Testicular and Seminal Parameters Under the HAART Era.

Authors:  Oluwatosin O Ogedengbe; Edwin C S Naidu; Onyemaechi O Azu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

2.  Southern Africa: the Highest Priority Region for HIV Prevention and Care Interventions.

Authors:  Sten H Vermund; Emily K Sheldon; Mohsin Sidat
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

3.  HIV self-screening distribution preferences and experiences among men who have sex with men in Mpumalanga Province: Informing policy for South Africa.

Authors:  O Radebe; S A Lippman; T Lane; H Gilmore; E Agnew; A Manyuchi; J A McIntyre
Journal:  S Afr Med J       Date:  2019-03-29

Review 4.  The global HIV epidemic: What the pathologist needs to know.

Authors:  Carlos Del Rio
Journal:  Semin Diagn Pathol       Date:  2017-05-19       Impact factor: 3.464

5.  Same day ART initiation versus clinic-based pre-ART assessment and counselling for individuals newly tested HIV-positive during community-based HIV testing in rural Lesotho - a randomized controlled trial (CASCADE trial).

Authors:  Niklaus Daniel Labhardt; Isaac Ringera; Thabo Ishmael Lejone; Phofu Masethothi; T'sepang Thaanyane; Mashaete Kamele; Ravi Shankar Gupta; Kyaw Thin; Bernard Cerutti; Thomas Klimkait; Christiane Fritz; Tracy Renée Glass
Journal:  BMC Public Health       Date:  2016-04-14       Impact factor: 3.295

6.  The impact of an unknown HIV serostatus on inpatient mortality.

Authors:  Yoshan Moodley
Journal:  Pan Afr Med J       Date:  2017-11-30

7.  Alcohol use and depression: link with adherence and viral suppression in adult patients on antiretroviral therapy in rural Lesotho, Southern Africa: a cross-sectional study.

Authors:  Bernard Cerutti; Barbara Broers; Motlomelo Masetsibi; Olatunbosun Faturiyele; Likabelo Toti-Mokoteli; Mokete Motlatsi; Joelle Bader; Thomas Klimkait; Niklaus D Labhardt
Journal:  BMC Public Health       Date:  2016-09-08       Impact factor: 3.295

8.  Modeling tuberculosis dynamics with the presence of hyper-susceptible individuals for Ho Chi Minh City from 1996 to 2015.

Authors:  Dao Nguyen Vinh; Dang Thi Minh Ha; Nguyen Thi Hanh; Guy Thwaites; Maciej F Boni; Hannah E Clapham; Nguyen Thuy Thuong Thuong
Journal:  BMC Infect Dis       Date:  2018-10-01       Impact factor: 3.090

9.  HIV-attributable causes of death in the medical ward at the Chris Hani Baragwanath Hospital, South Africa.

Authors:  Andrew Black; Freddy Sitas; Trust Chibrawara; Zoe Gill; Mmamapudi Kubanje; Brian Williams
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

10.  Effects of a peer educator program for HIV status disclosure and health system strengthening: Findings from a clinic-based disclosure support program in Mozambique.

Authors:  Carol Dawson-Rose; Sarah A Gutin; Florindo Mudender; Elsa Hunguana; Sebastian Kevany
Journal:  PLoS One       Date:  2020-05-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.